Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)

Abstract Background Older patients with HER2-positive metastatic breast (HER2 + MBC) cancer are underrepresented in clinical trials. We aim to describe the treatment patterns and overall survival (OS) for older women receiving trastuzumab for HER2 + MBC. Methods Retrospective, whole-of-population co...

Full description

Bibliographic Details
Main Authors: Benjamin Daniels, Belinda E. Kiely, Monica Tang, Hanna Tervonen, Sallie-Anne Pearson
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Cancer
Subjects:
HER2-positive
Metastatic breast cancer
Trastuzumab
HER2-targeted therapy
Older
Elderly
Online Access:http://link.springer.com/article/10.1186/s12885-019-6126-y

Internet

http://link.springer.com/article/10.1186/s12885-019-6126-y

Similar Items